Laura Benjamin
Director/Board Member at ALLARITY THERAPEUTICS, INC.
Profile
Laura E.
Benjamin is the founder of Oncxerna Therapeutics, Inc. founded in 2018, where she holds the title of President, Chief Executive Officer & Director.
She is currently an Independent Director at Allarity Therapeutics A and Allarity Therapeutics, Inc. Dr. Benjamin holds a doctorate degree from the University of Pennsylvania and an undergraduate degree from Barnard College.
Laura Benjamin active positions
Companies | Position | Start |
---|---|---|
ALLARITY THERAPEUTICS, INC. | Director/Board Member | - |
Oncxerna Therapeutics, Inc.
Oncxerna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Oncxerna Therapeutics, Inc. develops oncology drugs. The firm uses RNA-based biomarker platform. It focuses on clinical-stage therapies. The company was founded by Laura E. Benjamin in 2018 and is headquartered in Boston, MA. | Founder | 2017-12-31 |
Allarity Therapeutics A/S
Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark. | Director/Board Member | - |
Training of Laura Benjamin
University of Pennsylvania | Doctorate Degree |
Barnard College | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
ALLARITY THERAPEUTICS, INC. | Health Technology |
Private companies | 2 |
---|---|
Oncxerna Therapeutics, Inc.
Oncxerna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Oncxerna Therapeutics, Inc. develops oncology drugs. The firm uses RNA-based biomarker platform. It focuses on clinical-stage therapies. The company was founded by Laura E. Benjamin in 2018 and is headquartered in Boston, MA. | Health Technology |
Allarity Therapeutics A/S
Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark. | Health Technology |
- Stock Market
- Insiders
- Laura Benjamin